Format

Send to

Choose Destination
Ann Rheum Dis. 2017 Jan;76(1):29-42. doi: 10.1136/annrheumdis-2016-209707. Epub 2016 Jul 25.

2016 updated EULAR evidence-based recommendations for the management of gout.

Author information

1
AP-HP, hôpital Lariboisière, service de Rhumatologie, F-75010 Paris, France; Inserm, UMR1132, Hôpital Lariboisière, F-75010 Paris, France; Universitè Paris Diderot, Sorbonne Paris Citè, F-75205 Paris, France.
2
Academic Rheumatology, University of Nottingham, Nottingham, UK.
3
Department of Rheumatology, Hospital General Universitario de Alicante, Alicante, Spain.
4
Institute of Rheumatology RAMS, Moscow, Russia.
5
Department of Diagnostic and Interventional Radiology, Lausanne University Hospital, Lausanne, Switzerland.
6
AP-HP, Dèpartement d'Epidèmiologie et Recherche Clinique, Hôpital Bichat, Paris, France: APHP, Centre de Pharmacoèpidèmiologie, Paris, France: Univ Paris Diderot, Paris, France: INSERM UMR 1123 ECEVE, Paris, France.
7
Patient from Nottingham, UK, Paris.
8
Department of Rheumatology, VieCuri Medical Centre, Venlo, and Scientific IQ HealthCare, Radboud UMC, Nijmegen, The Netherlands.
9
Department of Primary and Community Care, Radboud University Medical Centre, Nijmegen, Netherlands.
10
Arthritis Research UK Primary Care Centre University of Keele, Keele, UK.
11
Osteoarticular Research Group, University of Edinburgh, Edinburgh, UK.
12
Seccion de Rheumatologia, Hospital de Cruces, Baracaldo, Spain.
13
Rheumatology Unit, Clínica Coração de Jesus, Lisbon, Portugal.
14
Rheumatology Unit, University of Padova, Padova, Italy.
15
Service de Rhumatologie, CHUV and Universitè de Lausanne, Lausanne, Switzerland.
16
Department of Rheumatology, University Clinic at the Technical University Dresden, Germany.
17
Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
18
Institute of Rheumatology, Prague, and Department of Rheumatology, First Faculty of Medicine, Charles University in Prague, Czech Republic.

Abstract

BACKGROUND:

New drugs and new evidence concerning the use of established treatments have become available since the publication of the first European League Against Rheumatism (EULAR) recommendations for the management of gout, in 2006. This situation has prompted a systematic review and update of the 2006 recommendations.

METHODS:

The EULAR task force consisted of 15 rheumatologists, 1 radiologist, 2 general practitioners, 1 research fellow, 2 patients and 3 experts in epidemiology/methodology from 12 European countries. A systematic review of the literature concerning all aspects of gout treatments was performed. Subsequently, recommendations were formulated by use of a Delphi consensus approach.

RESULTS:

Three overarching principles and 11 key recommendations were generated. For the treatment of flare, colchicine, non-steroidal anti-inflammatory drugs (NSAIDs), oral or intra-articular steroids or a combination are recommended. In patients with frequent flare and contraindications to colchicine, NSAIDs and corticosteroids, an interleukin-1 blocker should be considered. In addition to education and a non-pharmacological management approach, urate-lowering therapy (ULT) should be considered from the first presentation of the disease, and serum uric acid (SUA) levels should be maintained at<6 mg/dL (360 µmol/L) and <5 mg/dL (300 µmol/L) in those with severe gout. Allopurinol is recommended as first-line ULT and its dosage should be adjusted according to renal function. If the SUA target cannot be achieved with allopurinol, then febuxostat, a uricosuric or combining a xanthine oxidase inhibitor with a uricosuric should be considered. For patients with refractory gout, pegloticase is recommended.

CONCLUSIONS:

These recommendations aim to inform physicians and patients about the non-pharmacological and pharmacological treatments for gout and to provide the best strategies to achieve the predefined urate target to cure the disease.

KEYWORDS:

Gout; Multidisciplinary team-care; Treatment

PMID:
27457514
DOI:
10.1136/annrheumdis-2016-209707
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center